$0.00
(0.00%)
| Today's Open | $4.76 |
|---|---|
| Previous Close | $4.69 |
| Daily Range | $4.72 - $5.10 |
| 52-Week Range | $2.55 - $6.25 |
| Market Cap | $188.4M |
| P/E Ratio | -13.03 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 524,006 |
| Average Daily Volume | 266,367 |
| Current FY EPS | $0.00 |
Sector
Healthcare
Industry
Drugs
Ampio Pharmaceuticals, Inc. (AMPE) Description
Ampio Pharmaceuticals Inc. is engaged in developing innovative proprietary pharmaceutical drugs and diagnostic products to identify treat and prevent a broad range of human diseases including metabolic disorders cancer etc. Website: http://www.ampiopharma.com/
News & Commentary
Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the
Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the KneeAmpio Receives FDA Acceptance for Clinical Trial of Ampion for Treatment of Osteoarthritis of the Kn
Ampio Receives FDA Acceptance for Clinical Trial of Ampion for Treatment of Osteoarthritis of the KneeUPDATE: Aegis Capital Reiterates Buy Rating, Raises PT on Ampio Pharmaceuticals on Clinical Mileston
UPDATE: Aegis Capital Reiterates Buy Rating, Raises PT on Ampio Pharmaceuticals on Clinical Milestones